Vitronectin in human breast carcinomas
Authors:
- Birgitte V. OffersenBOBirgitte V. Offersen
- Anni ChristensenACAnni Christensen
- Peter A. AndreasenPAPeter A. Andreasen
- 1 May 2003
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1638 (1) , 72-82
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk Fonden
- Kræftens Bekæmpelse
- Sundhed og Sygdom, Det Frie Forskningsråd
This publication has 49 references indexed in Scilit:
- Acute Phase Protein α1-Acid Glycoprotein Interacts with Plasminogen Activator Inhibitor Type 1 and Stabilizes Its Inhibitory ActivityJournal of Biological Chemistry, 2001
- Type 1 Plasminogen Activator Inhibitor Binds to Fibrin via VitronectinJournal of Biological Chemistry, 2000
- Expression and Localization of αv Integrins and Their Ligand Vitronectin in Normal Ovarian Epithelium and in Ovarian CarcinomaGynecologic Oncology, 1996
- Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and α2-macroglobulin receptor in human breast carcinomasInternational Journal of Cancer, 1996
- Mode of tumor invasion in oral squamous cell carcinoma: Improved grading based on immunohistochemical examination of extracellular matricesHead & Neck, 1996
- Vitronectin and its receptorsCurrent Opinion in Cell Biology, 1993
- Interconversions between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitorBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1993
- Type‐1 plasminogen activator inhibitor in human breast carcinomasInternational Journal of Cancer, 1992
- Tissue Vitronectin in Normal Adult Human Dermis Is Non-Covalently Bound to Elastic TissueJournal of Investigative Dermatology, 1991
- Immunohistochemical Localization of Urokinase- and Tissue-Type Plasminogen Activators in Psoriatic SkinJournal of Investigative Dermatology, 1987